BeStock  
Stocks › Biotechnology › IMTX

Immatics IMTX

US equityMarket cap rank #3162Biotechnology
$7.45 −$0.05 (-0.67%)
Pre-market · Oct 8, 7:30 am ET · After hours $7.88 +5.77%
Open$7.44
Prev close$7.50
Day range$7.31 – $7.70
Volume926.2K
Market cap$1.11B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership85.4%-1.62 pts vs. prior quarter
Institutions holding93-2 vs. prior quarter
Insider trades (recent)12 buys / 0 sellsNet buying
Short interest2.97% of floatDays to cover 8.3 · as of 15 Sep 2026
Short-sale volume share10.6%5-day average of daily volume

Short-sale volume as % of daily volume

4%11%19%27%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$8.41M (1 inflow days, 19 outflow days).

Net flow by order size, last 20 sessions

−$7.2MSuper−$1.2MBig−$2.6MMid−$2.1MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 53.4% of shares outstanding.

Largest holders

  • T. Rowe Price Group, Inc.16.66%
  • dievini Hopp BioTech holding GmbH & Co. KG10.90%
  • RTW Investments, LP9.47%
  • Perceptive Advisors LLC8.19%
  • Montanova Capital, LLC8.19%
  • Baker Bros. Advisors LP6.96%
  • Jefferies Financial Group Inc.4.76%
  • Vestal Point Capital, LP4.52%

By investor type

  • Hedge Fund34.25%
  • VC/PE Fund21.80%
  • Mutual Fund21.57%
  • Public Company6.76%
  • Individual/Insider3.45%
  • Government Pension Fund0.51%
  • Private Company0.46%
  • Sovereign Wealth Fund0.01%

Reported short interest has fallen from 3.96% to 2.97% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Doliver Advisors, L.P. Mutual Fund 2026/Q3 +30,000 0.0%
Perceptive Advisors LLC VC/PE Fund 2026/Q3 +815,060 8.2%
Jefferies Financial Group Inc. Public Company 2026/Q3 +1,447,251 4.8%
Boxer Capital Management, LLC Hedge Fund 2026/Q3 +475,000 0.3%
T. Rowe Price Group, Inc. Mutual Fund 2026/Q3 +471,426 16.7%
Moore Capital Management, LP Hedge Fund 2026/Q3 +192,770 0.1%
Sectoral Asset Management Inc. Mutual Fund 2026/Q3 +158,098 0.2%
The Goldman Sachs Group, Inc. Public Company 2026/Q3 +156,962 0.3%
Qube Research & Technologies Ltd Mutual Fund 2026/Q3 +156,445 0.4%
Wellington Management Group Mutual Fund 2026/Q3 +85,960 1.2%
Jane Street Group, LLC Private Company 2026/Q3 +85,605 0.1%
RTW Investments, LP Hedge Fund 2026/Q3 +76,836 9.5%
D. E. Shaw & Co., L.P. Hedge Fund 2026/Q3 +59,161 0.0%
Leap Investments LP Mutual Fund 2026/Q3 +57,713 0.1%
Macquarie Group Limited Public Company 2026/Q3 +53,500 0.0%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
25 Aug 2026 Perceptive Advisors LLC Private Acquisition +863,060 $8.69 11,246,516
13 Aug 2026 James Pepin General Counsel Other Derivative Acquisition +43,800 – 43,800
13 Aug 2026 James Pepin General Counsel Other Derivative Acquisition +181,200 $9.44 181,200
15 Jun 2026 Michael Atieh Independent Non-Executive Director Other Derivative Acquisition +48,000 $9.09 48,000
15 Jun 2026 Peter Chambré Non-Executive Chairperson Other Derivative Acquisition +48,000 $9.09 48,000
15 Jun 2026 Heather Mason Independent Vice Chair of the Board of Directors Other Derivative Acquisition +48,000 $9.09 48,000
15 Jun 2026 Perceptive Advisors LLC Other Derivative Acquisition +48,000 $9.09 48,000
15 Jun 2026 Eliot Forster Independent Non-Executive Director Other Derivative Acquisition +48,000 $9.09 48,000
15 Jun 2026 Paul Carter Independent Non-Executive Director Other Derivative Acquisition +48,000 $9.09 48,000
15 Jun 2026 Mathias Hothum Non-Executive Director Other Derivative Acquisition +48,000 $9.09 48,000
15 Jun 2026 Alise Reicin Director Other Derivative Acquisition +48,000 $9.09 48,000
15 Jun 2026 Adam Stone Independent Non-Executive Director Other Derivative Acquisition +48,000 $9.09 48,000
17 Mar 2026 Michael Atieh Independent Non-Executive Director Initial Statement of Beneficial +0 – 171,500
17 Mar 2026 Peter Chambré Non-Executive Chairperson Initial Statement of Beneficial +0 – 383,474
17 Mar 2026 Heather Mason Independent Vice Chair of the Board of Directors Initial Statement of Beneficial +0 – 171,500
17 Mar 2026 Perceptive Advisors LLC Initial Statement of Beneficial +0 – 10,383,456
17 Mar 2026 Harpreet Singh CEO, MD, Member of Management Board & Executive Director Initial Statement of Beneficial +0 – 4,509,684
17 Mar 2026 Carsten Reinhardt Chief Development Officer Initial Statement of Beneficial +0 – 1,065,501
17 Mar 2026 Eliot Forster Independent Non-Executive Director Initial Statement of Beneficial +0 – 171,500
17 Mar 2026 Paul Carter Independent Non-Executive Director Initial Statement of Beneficial +0 – 171,500

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 4,438,234 3.0% 8.3
31 Aug 2026 4,853,483 3.2% 6.4
14 Aug 2026 4,921,838 3.6% 14.9
31 Jul 2026 5,028,154 3.7% 11.7
15 Jul 2026 5,047,260 3.7% 13.4
30 Jun 2026 5,408,927 4.0% 13.3

Discussion

No comments yet — be the first to weigh in on IMTX.

Leave a comment

Scroll to Top